Leaflet MIFEGYNE 200mg tablets

Indicated for: medical termination of pregnancy

Route of administration: oral

Substance: mifepristone (hormone)

ATC: G03XB01 (Genito urinary system and sex hormones | Other sex hormones and modulators of the genital system | Progesterone receptor modulators)

Precautions:
Breastfeeding warning
Breastfeeding warning

Use during breastfeeding only on medical advice.

Pregnancy warning
Pregnancy warning

Use during pregnancy only on medical advice.

Mifepristone is a medication used for terminating early pregnancies, typically up to 10 weeks of gestation. It acts as a progesterone receptor antagonist, blocking the effects of this hormone essential for maintaining pregnancy.

The medication is taken orally under medical supervision and is often used in combination with misoprostol to increase effectiveness. It is effective in inducing medical abortion.

Side effects may include nausea, vomiting, abdominal cramps, and vaginal bleeding. In rare cases, severe complications such as infections or hemorrhage may occur. Close monitoring is essential.

Consult your doctor to discuss the benefits and risks of treatment with Mifepristone. This medication must be used exclusively under medical supervision.

General data about MIFEGYNE 200mg

  • Substance: mifepristone
  • Date of latest medicines list: 01-06-2026
  • Product code: W53133001
  • Concentration: 200mg
  • Pharmaceutical form: tablets
  • Quantity: 1
  • Product type: Original
  • Price: 109.78 RON
  • Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Marketing authorisation

  • Manufacturer: LABORATOIRES MACORS - FRANTA
  • Holder: EXELGYN - FRANTA
  • Number: 10129/2017/01
  • Shelf life: 4 years

Concentrations available for mifepristone

  • 200mg
  • 600mg

Combinations with other substances